This would be by no means unprecedented; endogenous protease inhibitors are widespread in biological systems, where they often play crucial roles, and although protein-based peptidase inhibitors are relatively sparse in prokaryotes and unicellular eukaryotes [59], they have previously been identified in the malaria parasite for other peptidase classes [60–62]. The gene discussed is LAP3; the disease is malaria.